HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tianyu Li Selected Research

Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)

8/2020Interferon Regulatory Factor-2 Binding Protein 2 Ameliorates Sepsis-Induced Cardiomyopathy via AMPK-Mediated Anti-Inflammation and Anti-Apoptosis.
1/2020Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
1/2017Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tianyu Li Research Topics

Disease

69Neoplasms (Cancer)
11/2022 - 12/2005
24Breast Neoplasms (Breast Cancer)
05/2022 - 12/2005
12Prostatic Neoplasms (Prostate Cancer)
02/2018 - 11/2007
11Neoplasm Metastasis (Metastasis)
11/2022 - 03/2008
8Carcinoma (Carcinomatosis)
01/2018 - 10/2007
7Inflammation (Inflammations)
06/2022 - 01/2018
5Coronary Artery Disease (Coronary Atherosclerosis)
06/2022 - 01/2021
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2012
5Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2017
4Osteoporosis
06/2022 - 10/2020
4Obesity
06/2022 - 12/2008
4Wounds and Injuries (Trauma)
01/2022 - 11/2016
4Triple Negative Breast Neoplasms
01/2022 - 03/2009
4Fibrosis (Cirrhosis)
01/2022 - 09/2011
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 04/2011
4Myocardial Infarction
01/2021 - 01/2018
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 05/2016
4Reperfusion Injury
01/2020 - 06/2014
4Carcinogenesis
06/2017 - 04/2012
4Esophageal Neoplasms (Esophageal Cancer)
12/2012 - 07/2009
3Leukemia
12/2022 - 10/2011
3Type 2 Diabetes Mellitus (MODY)
09/2022 - 01/2021
3Pathologic Complete Response
05/2022 - 10/2007
3Acute Coronary Syndrome
04/2022 - 01/2021
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2020
3Hypertension (High Blood Pressure)
01/2021 - 10/2019
3Rectal Neoplasms (Rectal Cancer)
11/2019 - 05/2009
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 12/2010
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2016 - 08/2008
3Cholangiocarcinoma
08/2014 - 07/2010
3Adenocarcinoma
06/2014 - 08/2007
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2013 - 04/2012
2Non-alcoholic Fatty Liver Disease
11/2022 - 01/2020
2Ischemic Stroke
06/2022 - 04/2022
2Diabetes Mellitus
06/2022 - 07/2009
2Melanoma (Melanoma, Malignant)
03/2022 - 01/2018
2Hypoxia (Hypoxemia)
03/2022 - 01/2020
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 10/2021
2Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2021
2Sepsis (Septicemia)
01/2021 - 08/2020

Drug/Important Bio-Agent (IBA)

14Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022 - 08/2014
9Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2014
9Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2010
7Long Noncoding RNAIBA
12/2022 - 03/2018
7RNA (Ribonucleic Acid)IBA
12/2022 - 11/2019
6Glucose (Dextrose)FDA LinkGeneric
12/2022 - 05/2009
6Hormones (Hormone)IBA
05/2022 - 10/2015
6CytokinesIBA
03/2022 - 06/2014
6SeleniumIBA
03/2020 - 08/2014
5Particulate MatterIBA
11/2022 - 12/2020
5Pharmaceutical PreparationsIBA
06/2022 - 01/2013
5CollagenIBA
10/2021 - 06/2014
5Estrogens (Estrogen)FDA Link
01/2021 - 12/2005
4Trastuzumab (Herceptin)FDA Link
05/2022 - 08/2021
4Messenger RNA (mRNA)IBA
01/2022 - 01/2018
3LuciferasesIBA
12/2022 - 03/2018
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2022 - 07/2012
3CateninsIBA
06/2022 - 10/2011
3Cisplatin (Platino)FDA LinkGeneric
03/2022 - 01/2017
3Circular RNAIBA
01/2022 - 05/2021
3seleninic acidIBA
01/2022 - 02/2020
3Biological ProductsIBA
01/2022 - 03/2018
3AntioxidantsIBA
10/2021 - 06/2018
3eribulinFDA Link
09/2021 - 10/2020
3Small Interfering RNA (siRNA)IBA
01/2021 - 08/2014
3pembrolizumabIBA
01/2021 - 01/2020
3Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA
08/2020 - 01/2017
3Carrier Proteins (Binding Protein)IBA
08/2020 - 01/2017
3HomocysteineIBA
01/2019 - 01/2015
3PlatinumIBA
06/2018 - 08/2014
3Aromatase InhibitorsIBA
12/2006 - 12/2005
2Peptides (Polypeptides)IBA
11/2022 - 01/2020
2Fatty Acids (Saturated Fatty Acids)IBA
09/2022 - 06/2017
2Tissue Plasminogen Activator (Alteplase)FDA Link
06/2022 - 04/2022
2Paclitaxel (Taxol)FDA LinkGeneric
05/2022 - 11/2021
2pertuzumabIBA
05/2022 - 09/2021
2ErbB Receptors (EGF Receptor)IBA
05/2022 - 09/2014
2Matrix Metalloproteinases (MMPs)IBA
04/2022 - 10/2021
2NucleotidesIBA
01/2022 - 06/2014
2Estrogen ReceptorsIBA
01/2022 - 12/2005
2LipopolysaccharidesIBA
01/2022 - 02/2020
2Pemetrexed (MTA)FDA Link
01/2022 - 10/2020
2human ERBB2 proteinIBA
11/2021 - 09/2021
2Blood Glucose (Blood Sugar)IBA
06/2021 - 07/2009
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2020
2Phenobarbital (Luminal)FDA Link
01/2021 - 01/2018
2Small Cytoplasmic RNAIBA
01/2021 - 11/2019

Therapy/Procedure

29Therapeutics
05/2022 - 12/2006
25Radiotherapy
03/2022 - 10/2007
11Drug Therapy (Chemotherapy)
01/2022 - 03/2009
7Segmental Mastectomy (Lumpectomy)
01/2016 - 03/2009
6Percutaneous Coronary Intervention
04/2022 - 01/2021
6Neoadjuvant Therapy
01/2022 - 08/2008
5Chemoradiotherapy
12/2012 - 10/2007
4Immunotherapy
03/2022 - 03/2020
4Nephrectomy
01/2019 - 10/2011
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2013
3Aftercare (After-Treatment)
09/2013 - 12/2006
2Adjuvant Chemotherapy
05/2022 - 06/2014
2Intraperitoneal Injections
01/2021 - 08/2020